Investigating and understanding gene-environment interaction (G Â E) in a neurodevelopmentally and biologically plausible manner is a major challenge for schizophrenia research. Hypoxia during neurodevelopment is one of several environmental factors related to the risk of schizophrenia, and links between schizophrenia candidate genes and hypoxia regulation or vascular expression have been proposed. Given the availability of a wealth of complex genetic information on schizophrenia in the literature without knowledge on the connections to environmental factors, we now systematically collected genes from candidate studies (using SzGene), genome-wide association studies (GWAS) and copy number variation (CNV) analyses, and then applied four criteria to test for a (theoretical) link to ischemia-hypoxia and/or vascular factors. In all, 55% of the schizophrenia candidate genes (n = 42 genes) met the criteria for a link to ischemia-hypoxia and/or vascular factors. Genes associated with schizophrenia showed a significant, threefold enrichment among genes that were derived from microarray studies of the ischemia-hypoxia response (IHR) in the brain. Thus, the finding of a considerable match between genes associated with the risk of schizophrenia and IHR and/or vascular factors is reproducible. An additional survey of genes identified by GWAS and CNV analyses suggested novel genes that match the criteria. Findings for interactions between specific variants of genes proposed to be IHR and/or vascular factors with obstetric complications in patients with schizophrenia have been reported in the literature. Therefore, the extended gene set defined here may form a reasonable and evidence-based starting point for hypothesis-based testing of G Â E interactions in clinical genetic and translational neuroscience studies.
Current theories for the pathogenesis of schizophrenia hold that complex interactions between external and genetic factors adversely affect brain development. [1] [2] [3] [4] Early developmental perturbation are proposed to leave behind subtle deficits in widely distributed neuronal circuits, and pose the individual at an increased risk of psychosis during later stages in life. It has been proposed that schizophrenia arises slowly from subclinical psychotic symptoms that become abnormally persistent when synergistically combined with environmental exposures during development that may impact on behavioral and neurotransmitter sensitization. 5, 6 Findings in genetic epidemiology indicate that a multitude of genetic variants likely interact with environmental factors in complex ways (gene-environment interaction (G Â E)). Variable findings for genetic associations and small effects as observed in the first phase of the genetic literature suggest that schizophrenia represents a genetically complex and clinically heterogeneous disorder.
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Rationale for a gene-hypoxia interaction hypothesis in schizophrenia
Epidemiological research has reported that pre-and perinatal periods of distress are associated with an increased risk of schizophrenia later in life. [10] [11] [12] [13] [14] Recent epidemiological studies further document the relationship between obstetric complications and schizophrenia, psychosis-like symptoms or deficits in cognitive function. 15, 16 Using standardized scales that comprehensively evaluate and weight the presumed potential for obstetric conditions and events to cause central nervous system damage, several case-control studies revealed higher scores on obstetric complication scales for patients with schizophrenia than for healthy individuals. 10, [17] [18] [19] Fetal hypoxia has been proposed as a common denominator for most of these pre-and perinatal events. 4 , 10 Hypoxia becomes pathological when the severity or duration of decreased oxygenation has a detrimental impact on the tissue. However, low levels of oxygenation are also required as a physiological state in the developing embryo that serves as a signal for vessel development. 20, 21 Experimental work in embryos showed that the level of oxygenation is critical for the formation of the neural fold 22 and for the proper closure of the anterior neural tube by controlling apoptosis. 23 An experimentally induced change in oxygenation by hyperglycemia at a critical stage of development leads to oxidative stress and neural tube deficits. 24 Hypoxia-inducible factor 1 (HIF-1) is the main transcriptional factor that regulates the effects of hypoxia on the expression of genes for angiogenesis, glycolysis and protective responses. 25 HIF-1 is of key importance for embryonic development in general and for neural fold formation in specific. 21 Recent studies have also linked the major developmental regulator, NOTCH, to hypoxia and HIF-1. 26 It is important to note that in theory (and likely also in vivo), variations in oxygenation can influence gene expression during development; vice versa, gene variants can also influence the reaction to hypoxia. Given the close interrelations between oxygenation and vasculature, a developmental scenario has to include considerations for the vascular development in the brain, that is, vasculogenesis and angiogenesis. Consistent with this, multiple gene knockout experiments have indicated a key role for vascular genes in embryonic development, and angiogenesis of neural structures. 21, 27 Taken together, abnormal fluctuations in oxygenation during prolonged periods and/or vascular factors may lead to abnormal gene expression and lasting changes in neuronal circuitry in the developing brain, which are typically expressed without overt signs of tissue damage. Studying the effects of hypoxiaischemia during development on neuropsychiatric phenotypes is notoriously difficult and requires concerted work of epidemiology, genetics, molecular biology and basic neuroscience. While ongoing studies should establish whether hypoxic-ischemic conditions are a true and common denominator for the variety of obstetric complications associated with schizophrenia, one could start exploring the putative causal relationship by integrating the genetic information for schizophrenia-associated gene variants with evidence linking such genes to ischemia-hypoxia regulation and vascular functions.
Analytical approach to gene-hypoxia interaction in schizophrenia
With the aim to uncover indications for a role of hypoxia-ischemia regulation, we previously proposed to link the concept of gene-hypoxia interaction during development to the genetics of schizophrenia 28 through a multidisciplinary approach. In doing so, susceptibility genes for schizophrenia were compiled from the literature and evidence for regulation by hypoxia and ischemia for these genes was collected. Genes for schizophrenia were selected if at least two independent positive reports for association had appeared by the end of 2005. A meta-list of 16 gene expression studies from ischemia and hypoxia experiments of the brain formed the database of ischemia-hypoxia response (IHR) genes. 28 The analyses were carried out under the assumption that experimentally documented regulation in the adult brain also occurs during brain development. In addition, it was postulated that genes controlling vascular factors during development may affect oxygenation.
Since this initial analysis was completed by late 2005, 28 new developments have occurred in the field of schizophrenia genetics. First, candidate genes from association studies have been collected into the SzGene database, 29 which provides an evidence-based approach to sample genes for analysis. Second, results from the first wave of genome-wide association studies (GWAS) in schizophrenia have emerged and new genes have moved into the center of interest. Third, copy number variations (CNVs) have been systematically explored in schizophrenia. In parallel, more studies on gene expression profiling in ischemia-hypoxia of the brain have appeared, and knowledge in the area of vascular biology has strongly grown. It is thus timely to examine this new genetic information.
The present analysis aims to systematically select genes for association with schizophrenia and then test a match to four criteria linking the gene to ischemiahypoxia and vascular factors. We here present a combination of the 'initially matched' genes 28 and 'newly matched' genes. We will show that the relative number of matched genes from association studies remains above 50%. We report on links of these genes with neurodevelopment, report on associated biological pathways using bioinformatics, and list several novel genes that have emerged from GWAS and CNV studies. Furthermore, we describe the putative involvement of epigenetic mechanisms in the response to ischemia-hypoxia.
Selection of susceptibility genes from association studies
In the initial study, literature searches (PubMed) were performed and information for individual genes showing association with schizophrenia was collected. 28 Genes were selected when reported in nX2 independent publications using case-control design (that is, association studies) for schizophrenia. Genes directly related to dopamine and serotonin were set aside because of the ubiquitous effects of these transmitters on the cerebral circulation. 28 In this way, n = 28 genes were selected by the end of 2005. 28 For the present analyses, we continued gene collections from the original literature using the same approach between 2006 and 2009. Then, a comprehensive survey of new databases collecting genetic information was carried out. First, the genes listed under 'published candidate genes' in the SzGene database 29 were evaluated for meeting the criterion of nX2 positive studies in separate publications. Second, using the HuGE Navigator, a Phenocopia search for the key word 'schizophrenia' was carried out and links to PubMed used to collect details on the corresponding genes. Next, we combined genes from all sources and reviewed them under the set of criteria described below. As our working hypothesis relates to a multifactorial genetic model and different combinations of genes may be involved in different cases, we did not exclude genes according to negative studies. Thus, our selection and review is less stringent than the meta-analysis reported in SzGene. 29 Given the massive data-collection underlying reports of GWAS and CNVs, gene lists in the text or in supplemental materials were analyzed. Finally, novel genes emerging in the literature were collected in a separate pool, whereby the SzGene database of 'Recent Updates' was screened.
Criteria for ischemia-hypoxia regulation, HIF-related functions and vascular factors (A) The gene is listed in our database of 'ischemiahypoxia response (IHR) genes', which was built on a microarray study in brain ischemia. 30 Following the initial study on schizophrenia, 28 the IHR gene database was manually updated and has grown to a collection of information from 24 gene expression microarray studies. 31 It contains information for about n = 1750 genes (that is, approximately 9% of the human genome, assuming a low total number of 20 000 genes in the human genome) that are up-or downregulated by various types of brain ischemia-hypoxia in rats and mice. 31 It can be used to perform statistical analyses of matched data sets from disease gene lists. Individual microarray studies generating a match are referenced below.
(B) The gene or protein was shown to be regulated by ischemia-hypoxia in the brain in specific studies identified through PubMed, but not listed in the IHR gene database. Studies using gene knock-out experiments to test roles in ischemia-hypoxia regulation in the brain were also considered.
(C) The gene had to be regulated by HIF-1 (or HIF-2) as a target gene. Regulators of HIF signaling were included. To this end, a HIF-related database was constructed from reviews 32, 33 and two original studies. 34, 35 (D) The gene had to have a role in vasculogenesis, angiogenesis or vascular function. A role in the brain (including the blood-brain barrier), in large extracranial vessels or endothelial cells was ascertained by screening PubMed abstracts. Studies on vascular smooth muscle cells were not considered.
The following measures were taken to enable stringent analyses. IHR genes previously reported under one criterion were now separated into those in the IHR gene-database 31 (criterion A) and those reported in the literature (criterion B). Thus, genes meeting criterion A could be subjected to a statistical comparison with the IHR gene list. The previously used criterion of neuroprotective roles was deemed too general and not used in the present analysis.
Matching procedure
Each selected schizophrenia candidate gene was first run against the IHR gene and HIF databases using the gene symbol, according to criteria (A) and (C). Then, the gene symbol or full gene name was combined with keywords 'ischemia', 'hypoxia' and 'vascular' for searches in PubMed (criteria B and D). Additional searches used 'angiogenesis', 'endothelial', 'flow' and 'blood-brain barrier' as keywords. A match of a selected susceptibility gene with one criterion was considered sufficient, whereby several genes met two criteria.
Result of the formal analysis of genes from association studies
All matched genes are listed in Table 1 along with an overview of the criteria. Genes that were matched in our previous analysis are indicated as '2006-Study', which provided references for the association with schizophrenia and for the match to criteria. 28 In total, n = 77 genes were selected for association with schizophrenia in nX2 studies, that is, these genes are susceptibility genes for schizophrenia by our definition. As described below in detail, n = 42 genes (55% of selected genes) could be matched to the criteria of ischemia-hypoxia regulation and/or vascular factors. When revisiting the n = 20 genes that matched the criteria in our previous analysis, 28 we found that n = 19/20 genes qualified for matching based on the renewed analysis (only NR4A2-NURR1 did not). Our analysis yielded two genes (DPYSL2, PLA2G4A) that previously did not meet the criteria but now matched as new studies had become available. Thus, our previous selection of genes was validated by the current criteria, and some of these are highlighted below along with fresh evidence for links to our criteria. A total of n = 23 'new' genes met the current criteria, and the details are provided below (see 'Newly matched genes from association studies'). Taken together, more than half of the genes associated with schizophrenia (42/77 = 55%) fulfilled at least one of the criteria. Matches with the IHR gene database (criterion A), accounted for n = 22 of the matched genes. The precise definition of IHR genes 31 allows for a calculation of the expected number of matches with any gene list: 1750/20 000 = 9%. Accordingly, one would expect n = 7 schizophrenia-related genes to be randomly matched. However, n = 22 genes (29%) matched the IHR gene database (w 2 test P < 0.0001). Vice versa, the chance of any gene being a schizophrenia-associated gene is 0.4% (77/20 000) whereas the observed number for schizophrenia-associated genes matched with IHR genes was 1.2% (22/1750). Thus, when considering only the microarray-based IHR gene data (criterion A), schizophrenia-associated genes were three times more likely to be ischemia-hypoxia regulated than would be expected by chance. Removing downregulated genes from the analysis would not change the conclusion. N = 13 matches were found based on literature searches of ischemia-hypoxia regulation (criterion B) and only one gene was related to downregulation (SRR). The database for HIF-related genes (criterion C) indicated a 1% chance for any gene being regulated by HIF (204/20 000). The observed match of schizophrenia-associated genes on this list was 4% (n = 3/77 genes).
In addition, n = 15 genes were matched to vascular factors using literature mining (criterion D). Note that some genes fulfilled two criteria as indicated in the Table 1 .
Taken together, 55% of the genes under consideration as susceptibility genes for schizophrenia could be tied to ischemia-hypoxia and/or vascular roles using the four criteria. One could argue that the strong match is caused by the low stringency when using nX2 association studies for selection of schizophrenia-related genes. Therefore, additional analyses with increasing stringencies were carried out. The match remained at 56% when using nX3 studies for selection, and it increased to 75% when using nX4 or nX5 studies for selection. Thus, the more often a given gene has been associated with schizophrenia, the more likely it is related to ischemia-hypoxia and/or vascular factors.
Revisiting the previously matched genes from association studies
The references for the association with schizophrenia and the match with the criteria were provided for n = 20 genes in the initial report. 28 Over the past years, the link to ischemia-hypoxia and vascular factors for several of these genes has been strengthened by additional information (which was also entered in Table 1 ). Importantly, four of the genes have been linked to obstetric complication and schizophrenia by single-nucleotide polymorphism analysis based on our suggestion. 36, 37 Experimental studies with preand post-natal hypoxia have also begun to focus on schizophrenia-related genes. Accordingly, some of the previously matched genes will be highlighted in the following.
AKT1, V-AKT murine thymoma viral oncogene homolog 1 As part of a neuroprotective signaling pathway, AKT1 has been implied in multiple brain ischemia-hypoxia studies. 28 Nicodemus et al. 37 have established a genetic link for an AKT1 variant, obstetric complications and the risk of schizophrenia. A second study has confirmed the association between AKT1 polymorphisms and obstetric complications in female patients with schizophrenia. 36 
BDNF, brain-derived neurotrophic factor
This neurotrophin provides the best example how a neuron-specific trophic factor has been discovered to have an important role in endothelial cells. BDNF released from endothelial cells exerts trophic functions. 38 Nicodemus et al. 37 found an association between BDNF single-nucleotide polymorphisms and obstetric complications in relation to schizophrenia. Cannon et al. 39 have found that a decreased response of BDNF to perinatal hypoxia in the serum correlated with an increased risk to develop schizophrenia. CHRNA7, cholinergic receptor, neuronal nicotinic, alpha polypeptide 7 Vascular functions of the alpha 7 nicotinic receptors have been further highlighted. 40 DTNBP1, dystrobrevin-binding protein 1 or dysbindin The gene has been linked to hypoxia in the study of obstetric complications and schizophrenia risk by Nicodemus et al. 37 In the initial study, we suggested a role in vasculature, 28 and direct evidence has now been presented that dysbindin is expressed in glial endfeet surrounding brain capillaries. 41 GRM3, glutamate receptor, metabotropic, 3 This gene also emerged as linked to the obstetric complications in schizophrenia. 37 In addition, an imaging study of the hippocampal volume in relation to obstetric complications and schizophrenia risk genes showed an effect of allelic variation of GRM3, but this was not specific for schizophrenia 42 (see below for further discussion).
MLC1, megalencephalic leukoencephalopathy with subcortical cysts gene Progress has been made in localizing the MLC1 protein, and expression in astrocytic endfeet at the blood-brain barrier was described. 43 MLC1 is associated with the dystrophin-glycoprotein complex 43 that in turn is related to dystrobrevin. NOTCH4, NOTCH Drosophila, homolog of 4 This gene has a variable history in terms of association studies, but it reemerged from GWAS studies. 44 The link between NOTCH4 and vascular functions has been strengthened by studies in human brain vessels, 45 and regulation by HIF-1 has been shown in endothelial cells. 46 NRG1, neuregulin 1 An experimental study under a neurodevelopmental hypothesis of schizophrenia showed that neuregulin is hypoxia regulated in the neonatal rat brain. 47 Importantly, NRG1 has been characterized as a systemic endogenous protector against perinatal inflammatory brain damage, and a single-nucleotide polymorphism associated with schizophrenia was found to be protective. 48 
PRODH, proline dehydrogenase
Recent studies have shown that variants of PRODH are associated with reduced proline oxidase activity, leading to hyperprolinemia, which in turn influences brain development. 49 Studies of the regulation of PRODH by external factors should be expanded.
RELN, reelin
An experimental study has shown that prenatal maternal hypoxia is associated with dysregulation of reelin levels in the fetal brain and abnormal neuronal migration. 50 Reelin deficiency increased stroke size in mice. 51 RGS4, regulator of G protein signaling 4 Downregulation by HIF has been described in endothelial cells. 46 RTN4, reticulon 4 Different NOGO proteins are generated by alternate splicing of RTN4. NOGO-A has been in the center of interest as an inhibitor for axonal growth in relation to the neurodevelopmental hypothesis. NOGO-B has been linked to vascular functions and additional studies have appeared. 52 How these splice variants relate to schizophrenia remains to be studied. RTN4R encodes the NOGO receptor that has also been reproducibly associated with schizophrenia 53 (but did not match the criteria directly).
Newly matched genes from association studies
The n = 23 newly matched genes are listed in Table 1 along with the criteria generating the match. Details for the studies used for selection of these genes based on two association reports in schizophrenia and studies generating the match to the four criteria are referenced in Supplementary File 1. Note that a new match could be brought about by a second positive association study appearing after the initial analysis (after 2006) or by the stringent use of the SzGene database. Our hypothesis implies that the matched genes are expressed in the brain during development. Evidence for expression in the developing mouse brain was retrieved using MGI Mouse Genome Informatics (http://www.informatics.jax.org/) whereby links to GENSAT provided images of the developing brain. Using this approach, expression in the developing brain could be ascertained for most newly matched genes, except for Chi3li, Egf, Mchr1 and Ppp3cc. EGF has strong effects in neural stem cells indicating a neurodevelopmental role. 54 
Pathway analysis of matched genes
Our study uses a specific annotation of schizophrenia genes under a set of complex criteria. We explored whether subsets of the genes selected in this way are preferentially connected to certain biological processes using the standardized, publically available annotation tool, DAVID (http://david.abcc.ncifcrf.gov/), 55, 56 which incorporates Gene Ontology (GO) terms. Entering the n = 42 matched genes into the analysis, the strongest annotations were 'transmission of nerve impulse' (n = 13, P = 6.6EÀ11), 'synaptic transmission' (n = 11, P = 5.18EÀ9) and 'cell-cell signaling' (n = 14, P = 8.9EÀ9). Matches with 'neuron projection' (n = 6, P = 4.66EÀ6), 'axon' (n = 5, P = 5.5EÀ6) and 'dendrite' (n = 4, P = 1.6EÀ4) reflect the importance of neuronal connectivity. The GO term 'developmental process' was assigned to n = 18 genes (P = 9.2EÀ4), that is, AKT1, BDNF, CCKAR, CHRNA7, DPYSL2, EGF, IL10, NEUROG1, NOTCH4, NRG1, OLIG2, PLXNA2, PRODH, RELN, RTN4, TNF, TP53 and UFD1L.
Genes from association studies not matching the criteria N = 35 genes were selected as associated with the risk of schizophrenia (that is, reported in nX2 studies) but did not show matches according to the four criteria. Thereby, 6/8 genes of the original study remained unmatched (FZD3, G72/DAOA, GSTM1, MTHFR, YWHAH and ZDHHC8). N = 29 new genes were identified for schizophrenia over the past years that could not be matched to the criteria (ACSL6, ARVCF, AHI1,  CDC42SE2, CHGB, CHL1, CNP, DISC1, EPSIN4,  ERBB4, GNB1L, GRID1, GRIN2B, IL3RA, KPNB3,   LTA, NRG3, NTNG1, PDLIM5, PICK1, PIK3C3, PIP5-K2A, RAPGEF6, RTN4R, SCA1, SIAT8B, SNAP29,  TAAR6 and TSNAX).
Preliminary findings from recent association studies
We wish to present in a preliminary fashion a selection of findings from more recent schizophrenia studies that suggest a relationship between susceptibility genes, ischemia-hypoxia and vascular factors. KCNH2/HERG was recently associated with risk of schizophrenia and schizophrenia-related alterations of cortical physiology, 57 and this is an IHR gene. 58 Heat shock proteins (HSPs) are major IHR genes, and alleles in HSPA1B have been linked to the risk of schizophrenia. 59 PRKCA has been suggested as a gene of interest for schizophrenia 60 and PRKCA is altered in brain ischemia.
61
SELENBP1 has been connected to schizophrenia by association 62 and by regulation in brain tissue 63 and this gene is HIF-1 regulated. 64 Recently, MET was linked to schizophrenia, 65 and the MET protein is the receptor for hepatocyte growth factor (HGF). Regulation of MET and HGF was shown in brain ischemia. 66 
Genes from GWAS
Results from several GWAS in schizophrenia have been reported. 44, [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] We have screened the available GWAS studies under our four criteria and found several interesting matches, see Supplementary File 2. References documenting the link between the genes and the criteria are provided in Supplementary File 2. Although these findings are in line with an interaction between several novel risk genes and ischemiahypoxia or vascular factors, differences in design and data presentation in different GWAS studies preclude a quantitative analysis.
Genes from chromosomal breakpoints and CNVs
Our hypothesis of gene-hypoxia interactions can be extended to rare genes deleted by chromosomal breakpoints. In the previous report, two genes were related to chromosomal breakage points, that is, NPAS3 and DISC1. 28 Since then, NPAS3 has been analyzed in two additional cases with translocations and schizophrenia, 81 and the gene has shown positive association.
82
NPAS3 remains of interest because of its similarity with other bHLH-PAS proteins that interact with the HIF-1 pathway. 28 Over the past years, DISC1 has been repeatedly studied for association and is now a leading candidate gene in schizophrenia.
83 DISC1 does not fulfill our criteria, but the proximity between DISC1 and EGLN1 (encoding PHD2, a major inhibitory regulator of HIF-1) should be noted. 28 Interestingly, genetic studies of human adaptation to hypoxia in high altitude have pointed to DISC1 84 or EGLN1.
85
Interactions between variants in DISC1 and EGLN1 deserve more study in relation to hypoxia.
Several studies on CNVs have recently been reported for schizophrenia. [86] [87] [88] [89] A flood of new genomic data has emerged from these studies. 77, 79, [90] [91] [92] [93] [94] [95] [96] [97] An increased number and/or size of CNVs has been reported for schizophrenia. [86] [87] [88] [89] Genes identified in CNV studies are of interest for our analysis. Expressivity of CNVs is variable indicating that external factors may be involved. Haploinsufficiency occurs in deletions, and the regulation of transcription from the intact allele by external factors could become critical, that is, hypoxia could have positive effects by increasing gene expression. If the increase in the gene dose by duplication is disruptive, a further increase in protein levels by hypoxic upregulation could aggravate a problem. In Supplementary File 3, we highlight several interesting genes reported in CNVs that match our criterion of IHR genes. Given that different criteria and platforms were used across different CNV studies, a statement as to the relative importance of the matched genes cannot be made at this point.
A hypoxic link to epigenetic regulation
Although no studies have yet provided direct evidence for epigenetic mediation of hypoxia-ischemia during pre-and perinatal life in schizophrenia, epigenetic regulation of gene expression (for example, through histone alterations, DNA methylation or microRNAs (miRNAs)) is an attractive candidate mechanism underlying the effects of pre-and perinatal exposure to hypoxia-ischemia on gene expression and aberrant neurodevelopmental processes. 98 Recent evidence indicated that histone demethylase enzymes, in particular Jumonji-domain-containing proteins, require oxygen to function and can be induced by hypoxia in an HIF-1-dependent manner.
99,100 For example, hypoxic conditions induce expression of KDM3A (lysine (K)-specific demethylase 3A; JHMD2A or JMJD1A), a zinc-finger protein that contains a jumonji domain and that is involved in regulation of self-renewal of stem cells. 101 Other jumonji-domaincontaining protein responsive to hypoxic conditions are KDM4C (lysine (K)-specific demethylase 4C; JMJD2C), a nuclear protein that functions as a trimethylationspecific demethylase, and lysine (K)-specific demethylase 4B KDM4B (JMJD2B). 102, 103 Indeed, association with JMJD2C has been found in a GWAS study 74 (see also Supplementary File 2). Recent genetic evidence from a GWAS analysis in combination with a large meta-analysis has suggested that common variants in a cluster of histone genes HIST1H2BJ, HIST1H2AG, HIST1H2BK, HIST1H4I and HIST1H2AH (at chromosome 6p22.1) are associated with a significantly increased risk of schizophrenia. 75 Other studies have indicated that DNA methylation can be influenced by exposure to a range of external environmental factors, either globally or at specific loci. 104 Exposure to hypoxic conditions was shown to be connected to altered DNA methylation patterns, at least in tumor tissue and prostate cells, 105, 106 while deficiency of DNA methyl transferase in the mouse central nervous system mitigated the damaging effects of focal ischemia. 107 In frontal cortex of schizophrenia patients, genome-wide interrogation of DNA methylation indicated aberrant profiles, particularly in genes involved in glutamatergic and GABAergic neurotransmission and brain development. 108 miRNAs have been also documented to regulate the response to hypoxia. 109 Elevated levels of miRNAs were found in the prefrontal cortex of patients afflicted by schizophrenia. 110 A recent GWAS study has shown a significant association with miRNA 137, 111 and astrocytes expressed elevated levels of miRNA 137 after oxygen-glucose deprivation in vitro.
112 Taken together, these findings suggest that hypoxic conditions influence histone tags, DNA methylation and miRNA profiles in the central nervous system, and further multidisciplinary research is warranted to identify direct links between hypoxia, epigenetic alterations and schizophrenia.
Endophenotypes for matched genes
One could speculate that genetic variations, in conjunction with hypoxia-type of insults and/or vascular dysfunction, could lead to subtle damage that can be expressed as a structural or functional endophenotype in the manifest disease state. Abnormal brain morphology in neuroimaging studies can serve as a putative endophenotype. Indeed, a study using a genetically sensitive design (schizophrenia cases, siblings and controls) showed that obstetric complications were associated with reduced gray matter and increased cerebrospinal fluid (CSF) space bilaterally throughout the cortex in patients but also in their siblings (versus controls), thus suggesting an interaction between indirect measures of genetic risk and fetal hypoxia. 113 Further studies using direct measures of genetic risk have correlated variations in brain morphology (that is, alterations in volume of brain regions) with polymorphisms in genes matching our criteria, for example, AKT1, 114 BDNF, 115 COMT, 116 DTNBP1, 117 and NRG1, 118 whereby the effects were in general larger for cases. Only one study (to the best of our knowledge) has specifically looked at the interaction between allelic variation (in GRM3) and obstetric complications in hippocampal volume and found an interaction, which, however, was not specific for schizophrenia. 42 Although obstetric complications were correlated with changes in hippocampal volume in that study, 42 no correlations were found for cortical thickness 119 or volume of basal ganglia. 120 Thus, issues of selective vulnerability to early insults need to be understood in more detail before genetic variation can be related to the risk of schizophrenia. A recent study compiled 12 candidate endophenotypes and tested associations with n = 94 candidate genes. 121 In this analysis, n = 46 genes showed significant associations with endophenotypes, 121 and out of these, n = 11 (24%) were genes of our selection matching the criteria whereas n = 2 (4%) did not.
These trend data open the possibility that endophe-notypes may be traced back to interactions between gene variants and early developmental insults. Importantly, some of the endophenotypes can be studied experimentally, and future investigations may look at interactions between selected genes matching our criteria and hypoxic insults.
Limitations of the hypothesis
The main findings in our study relate to the possible role of hypoxia during neurodevelopment, which was tested using the database of IHR genes of the brain, and resulted in a match for n = 22 or 29% of schizophrenia-related genes. One could argue that risk genes for schizophrenia may be associated with signaling in multiple pathways that relate to cell stress and damage. Two of the matched genes belong to the class of cytokines, that is, IL10 and TNF, suggesting that pathways of neuroinflammation could be involved. 122 To address the specificity of our findings, we entered the selection of risk genes associated with schizophrenia (n = 77) into the DAVID bioinformatics tool ('functional annotation chart') and searched for terms related to cell stress and damage (P < 0.001). This search returned 'Schizophrenia, susceptibility to' (as expected), 'multicellular organismal response to stress' (n = 5) and 'regulation of apoptosis' (n = 12). These categories are too broad to draw any conclusions regarding the specificity of findings. It has been argued that a pathway analysis by the present search tools is insufficient to find subtle links between genetic findings in schizophrenia, and therefore, expert-curated gene groups were formed, for example, for the analysis of synaptic genes. 123 Our databases of IHR genes and HIF-related genes has indeed followed the same principles. To examine whether our collection of risk genes for schizophrenia would match with additional gene lists if these were generated by collecting gene expression studies in cell stress and damage, we retrieved a list of genes that are regulated by endoplasmic reticulum stress from an experimental expression study. 124 This list contained n = 1717 genes related to endoplasmic reticulum stress, out of which n = 9 overlapped with the SCZ gene list (random value: n = 7). Furthermore, to test whether our collection of IHR genes would match with genes associated with the risk of other neurological or psychiatric conditions, we generated databases for genes related to the risk of autism, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis using similar criteria as in this study. When testing these gene lists against the IHR gene database, only risk genes for Alzheimer's disease generated a match comparable to the present analysis of schizophrenia-related genes. This gene list, however, contained different genes than for schizophrenia, which may be explained by aging-related vascular components of dementias (Schmidt-Kastner, unpublished observations).
Although recent reports using hypothesis-free approaches (GWAS studies) reflect a very important step forward finding 'true' associations, the variability in analyses and presentations of the most important hits for schizophrenia-susceptibility genes in the corresponding reports precludes an appropriate quantitative analysis. However, we have been able to generate an initial list of matched genes derived from GWAS and CNV studies in schizophrenia although these genes differ from those found by matching with genes from association studies in schizophrenia. This lack of mutual confirmation between different genetic approaches to the risk of schizophrenia is well recognized. 125 We wish to point out that at this time it appears easier to obtain additional information for environmental factors (including hypoxia-like events) from focused association studies 37 than from large data sets (from large pools of clinical cohorts) such as the current wave of GWAS and whole-genome encompassing CNV studies. Furthermore, the data sets generated by GWAS analysis may contain information relevant to our hypothesis that only emerges from more sophisticated analyses. A recent study examined whether schizophrenia susceptibility alleles from a GWAS study were enriched for alleles that affect gene expression in the adult human brain using an expression quantitative trait loci (eQTL) approach. 126 Using the statistical approaches specified in the paper, 126 n = 109 genes of interest were listed, which included four key genes of the HIF pathway, that is, HIF1A itself, its heterodimerization partner ARNT2 (forming HIF-1 beta), the inhibitor HIF1AN (FIH1) and AHR, which competes with HIF1A for the same heterodimerization partners. These novel findings provide additional evidence for the concept that hypoxia regulation and susceptibility genes for schizophrenia are linked at the level of gene expression, at least in the adult brain, and possibly, in the developing nervous system.
Concluding remarks
Understanding G Â E interaction is a major challenge for schizophrenia research. 4 We here focused on one of several possible environmental factors discussed in this disorder, namely ischemia-hypoxia during neurodevelopment. 13 We systematically collected genetic information for schizophrenia that has been obtained by candidate gene studies (including SzGene), GWAS and CNV analyses over the past years. We then applied four criteria to look for a link to ischemiahypoxia and/or vascular factors. Combining the candidate genes analyzed in the initial report 28 with the newly matched genes, n = 42 genes (55%) met our criteria. Using the IHR genes derived from microarray studies (criterion A), a significant, threefold enrichment for genes associated with schizophrenia were found. Thus, our finding of a considerable match between genes associated with the risk of schizophrenia and IHR and/or vascular factors withstood the test of time. A survey of genes identified by GWAS and CNV analyses suggests novel genes that match to our criteria. As variants of four of the genes originally identified by our theoretical approach 28 have been already linked to obstetric complications in a clinical study, 37 clinical genetic studies with the extended gene set defined here could advance the understanding of G Â E interactions during neurodevelopment. The genes highlighted in our review furthermore form a reasonable, evidence-based starting point for hypothesis-testing investigations. In the near future, deep resequencing will probably allow for the detection of even more risk genes based on rare missense mutations. The first study using deep resequencing in schizophrenia listed VEGF, encoding for the most important angiogenesis factor, among ten genes found in the initial analysis. 127 A very interesting in vitro approach would be to directly test the interaction of gene variants associated with the risk of schizophrenia and hypoxia in cells representative for the human brain. Indeed, a first study comparing induced pluripotent stem cells of patients with schizophrenia with those of controls showed reduced connectivity, decreased neurite number and altered gene expression in neurons from patients with schizophrenia. 128 Thus, it can be envisioned that we approach the exciting phase of employing translational G Â E studies on the role of hypoxia and vascular factors as interacting elements in the neurodevelopmental model of schizophrenia.
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